Skip to content

Effect of Lidocaine Intraperitoneal Injection on Perioperative Analgesia of Cesarean Section

Effect of Lidocaine Intraperitoneal Injection on Perioperative Analgesia of Cesarean Section

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100047683
Enrollment
Unknown
Registered
2021-06-21
Start date
2021-06-21
Completion date
Unknown
Last updated
2022-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean Section

Interventions

lidocacine group:Intraperitoneal lidocaine injection
normal saline group:Intraperitoneal injection of normal saline

Sponsors

Beijing Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Term primiparous women with singleton pregnancy; 2. American Society of Anesthesia (ASA) grade I-II; 3. Undergo abdominal cesarean section; 4. Anesthesia is combined spinal-epidural anesthesia, and PCEA is used for postoperative analgesia.

Exclusion criteria

Exclusion criteria: 1. Transperinatal or previous abdominal surgery (laparotomy or laparoscopy); 2. Extraperitoneal cesarean section; 3. Lidocaine allergies; 4. Disagree to sign the informed consent; 5. Combined with preeclampsia, eclampsia, arrhythmia or other genetic diseases, rare diseases or serious systemic diseases: dwarfism, nervation, dementia, epilepsy, etc.

Design outcomes

Primary

MeasureTime frame
Resting pain score;Exercise pain score;

Secondary

MeasureTime frame
Nausea and vomiting during bilateral ovarian exploration;Nausea and vomiting when closing the peritoneum;Comfort during bilateral ovarian exploration;Comfort when suturing the peritoneum;

Countries

China

Contacts

Public ContactLi Junfeng

Beijing Hospital

18510780408@163.com+86 18510780408

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026